![B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb® B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®](https://mma.prnewswire.com/media/1447289/B_Braun_OMNI.jpg?p=facebook)
B. Braun Avitum AG and CytoSorbents Corporation Announce Global Co-Marketing Agreement to Promote the OMNI® Continuous Blood Purification Platform with CytoSorb®
![AVA, B. Braun Partnership Continues to Raise Standards for PIV Education and Training with Launch of New Certificate Course on Vascular Access AVA, B. Braun Partnership Continues to Raise Standards for PIV Education and Training with Launch of New Certificate Course on Vascular Access](https://mma.prnewswire.com/media/1911234/B_Braun_AVA_Logo.jpg?p=facebook)
AVA, B. Braun Partnership Continues to Raise Standards for PIV Education and Training with Launch of New Certificate Course on Vascular Access
![B. Braun Interventional Systems Inc., an Affiliate of B. Braun Medical Inc., and Infraredx, a Nipro Company, Announce Strategic U.S. Collaboration to Execute the IDE Clinical Trial for the SeQuent(R) Please ReXTM B. Braun Interventional Systems Inc., an Affiliate of B. Braun Medical Inc., and Infraredx, a Nipro Company, Announce Strategic U.S. Collaboration to Execute the IDE Clinical Trial for the SeQuent(R) Please ReXTM](https://www.dailylocal.com/wp-content/uploads/migration/2021/03/4fcd7bbebca2246a931cb72bee63067f.jpg?w=1024)